Hemoglobin A1c variability as an independent correlate of cardiovascular disease in patients with type 2 diabetes: a cross-sectional analysis of the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study.
about
Association of the average rate of change in HbA1c with severe adverse events: a longitudinal evaluation of audit data from the Bavarian Disease Management Program for patients with type 2 diabetes mellitus.Distribution of cardiovascular disease and retinopathy in patients with type 2 diabetes according to different classification systems for chronic kidney disease: a cross-sectional analysis of the renal insufficiency and cardiovascular events (RIACE)Relationship of HbA1c variability, absolute changes in HbA1c, and all-cause mortality in type 2 diabetes: a Danish population-based prospective observational studyTreatment-dependent and treatment-independent risk factors associated with the risk of diabetes-related events: a retrospective analysis based on 229,042 patients with type 2 diabetes mellitus.Cardiovascular events and all-cause mortality in a cohort of 57,946 patients with type 2 diabetes: associations with renal function and cardiovascular risk factorsThe association between glycemic variability and diabetic cardiovascular autonomic neuropathy in patients with type 2 diabetes.HbA1c below 7% as the goal of glucose control fails to maximize the cardiovascular benefits: a meta-analysisDelay in treatment intensification increases the risks of cardiovascular events in patients with type 2 diabetes.Lack of correlation between the optimal glycaemic control and coronary micro vascular dysfunction in patients with diabetes mellitus: a cross sectional studyAdjustment of the GRACE score by HemoglobinA1c enables a more accurate prediction of long-term major adverse cardiac events in acute coronary syndrome without diabetes undergoing percutaneous coronary interventionAssociation between glycemic control and antidiabetic drugs in type 2 diabetes mellitus patients with cardiovascular complicationsLetter: a1c variability can predict coronary artery disease in patients with type 2 diabetes with mean a1c level greater than 7 (endocrinol metab 2013;28:125-32, eun ju lee et Al.).Thresholds of various glycemic measures for diagnosing diabetes based on prevalence of retinopathy in community-dwelling Japanese subjects: the Hisayama Study.Long-term Variability in Glycemic Control Is Associated With White Matter Hyperintensities in APOE4 Genotype Carriers With Type 2 Diabetes.HbA1c, systolic blood pressure variability and diabetic retinopathy in Asian type 2 diabetics.Response: a1c variability can predict coronary artery disease in patients with type 2 diabetes with mean a1c level greater than 7 (endocrinol metab 2013;28:125-32, eun ju lee et Al.).Diabetes Camp as Continuing Education for Diabetes Self-Management in Middle-Aged and Elderly People with Type 2 Diabetes Mellitus.Hemoglobin A1c Variability Predicts Symptoms of Depression in Elderly Individuals With Type 2 Diabetes.Identifying the independent effect of HbA1c variability on adverse health outcomes in patients with Type 2 diabetes.Liraglutide Improves Glycemic and Blood Pressure Control and Ameliorates Progression of Left Ventricular Hypertrophy in Patients with Type 2 Diabetes Mellitus on Peritoneal Dialysis.Prognostic impact of HbA1c variability on long-term outcomes in patients with heart failure and type 2 diabetes mellitus.
P2860
Q31013668-B12D1EC5-E759-4B84-A05C-70C5834B0F16Q33558940-B1AE1563-CF99-4634-B0C8-E29E0E0359D8Q35050565-5570D3B1-7025-4379-82F6-6FB3FADCEEBFQ35128612-85DFDCB1-B4B0-43AA-BEEC-0DB6B0D2E650Q35538153-811151CF-3915-4296-9E39-22FBD3DDEF93Q35711866-E519964D-666E-45AC-8F8A-B8085409A0B3Q35782729-DD393FD4-0E45-493E-9829-61A0DF67CB64Q35927578-5F0F5B0F-5BBC-46AF-8411-303D44C3CE55Q35951214-8EBC9E66-BDED-4163-973E-35ED4CB73FFDQ35971451-CA22DD63-4F84-411F-AEA2-A633D14C48EBQ35991064-EF72C395-3359-4B80-9712-C4796F7AB1DEQ37410176-E0CF631C-70C1-4689-8645-395B2A9FE085Q37607364-4FFC09A7-86C6-4AEE-A4C4-59E660DFF468Q37652814-2A281599-905A-4B9B-9613-9E22A924E6BEQ40364101-6D8F78DE-CB0C-44C3-BA9A-54E530FAB1F3Q41965614-BD7C18C7-0FA1-4002-9A70-52BF9FFA3A1AQ42290218-3D9C552F-A7E9-4FE6-B0B1-11039EF85947Q47850262-56CDEF11-1F0A-47BA-A24D-8DF84BAE5D4CQ48052763-E7988F67-6975-4737-9D63-079BD103AF18Q51294221-96FB6002-B685-4C7C-9AC9-3D06F974FB22Q55516149-8255A7C7-9AFB-4E33-BE23-C5AF45E40463
P2860
Hemoglobin A1c variability as an independent correlate of cardiovascular disease in patients with type 2 diabetes: a cross-sectional analysis of the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hemoglobin A1c variability as ...... CE) Italian multicenter study.
@en
Hemoglobin A1c variability as ...... ency and cardiovascular events
@nl
type
label
Hemoglobin A1c variability as ...... CE) Italian multicenter study.
@en
Hemoglobin A1c variability as ...... ency and cardiovascular events
@nl
prefLabel
Hemoglobin A1c variability as ...... CE) Italian multicenter study.
@en
Hemoglobin A1c variability as ...... ency and cardiovascular events
@nl
P2093
P2860
P50
P921
P356
P1476
Hemoglobin A1c variability as ...... CE) Italian multicenter study.
@en
P2093
Cecilia Fondelli
Franco Cavalot
Giacomo Zoppini
Gianpaolo Zerbini
Giuseppe Penno
Monica Vedovato
Olga Lamacchia
Renal Insufficiency and Cardiovascular Events (RIACE) Study Group
Roberto Trevisan
P2860
P2888
P356
10.1186/1475-2840-12-98
P407
P577
2013-07-05T00:00:00Z
P5875
P6179
1048691257